Table 3.
Responses to pembrolizumab and Y90 combination treatment by RECIST 1.1.
RECIST 1.1 category | Current RECIST response | Best RECIST response | ||
---|---|---|---|---|
N | Percent (95% CI) | Counts | Percent (95% CI) | |
ORR | 5 | 19.2 (6.6%, 39.4%) | 8 | 30.8 (14.3%, 51.8%) |
CR | 0 | 0 | ||
PR | 5 | 19.2 (6.6%, 39.4%) | 8 | 30.8 (14.3%, 51.8%) |
SD | 5 | 19.2 (6.6%, 39.4%) | 14 | 53.8 (33.4%, 73.4%) |
PD | 16 | 61.5 (40.6%, 79.8%) | 4 | 15.4 (4.4%, 34.9%) |